Jinxin Fertility Group Ltd
HKEX:1951
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
2.09
4.42
|
Price Target |
|
We'll email you a reminder when the closing price reaches HKD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Jinxin Fertility Group Ltd
Total Receivables
Jinxin Fertility Group Ltd
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Jinxin Fertility Group Ltd
HKEX:1951
|
Total Receivables
ÂĄ346.2m
|
CAGR 3-Years
30%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
||
Guangzhou Kingmed Diagnostics Group Co Ltd
SSE:603882
|
Total Receivables
ÂĄ5.7B
|
CAGR 3-Years
7%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
||
Topchoice Medical Co Inc
SSE:600763
|
Total Receivables
ÂĄ238.6m
|
CAGR 3-Years
9%
|
CAGR 5-Years
16%
|
CAGR 10-Years
32%
|
||
Nanjing Xinjiekou Department Store Co Ltd
SSE:600682
|
Total Receivables
ÂĄ1.6B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
35%
|
||
Dian Diagnostics Group Co Ltd
SZSE:300244
|
Total Receivables
ÂĄ9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
19%
|
CAGR 10-Years
37%
|
||
Meinian Onehealth Healthcare Holdings Co Ltd
SZSE:002044
|
Total Receivables
ÂĄ3.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
50%
|
Jinxin Fertility Group Ltd
Glance View
Jinxin Fertility Group Ltd. engages in the provision of assisted reproductive, management and ancillary medical services. The company is headquartered in Chengdu, Sichuan. The company went IPO on 2019-06-25. The firm operates its business through three segments. The ARS segment primarily provides its patients with two treatment solutions: artificial insemination (AI) and in vitro fertilization (IVF) technology. The Management Services segment provides management services to Jinjiang IVF Center and Jinxin Fertility Center. The Ancillary Medical Services segment mainly provides medical services in the areas of gynecology, urology and internal medicine through Shenzhen Zhongshan Hospital. The firm mainly operates its business in China and the Unites.
See Also
What is Jinxin Fertility Group Ltd's Total Receivables?
Total Receivables
346.2m
CNY
Based on the financial report for Dec 31, 2023, Jinxin Fertility Group Ltd's Total Receivables amounts to 346.2m CNY.
What is Jinxin Fertility Group Ltd's Total Receivables growth rate?
Total Receivables CAGR 5Y
18%
Over the last year, the Total Receivables growth was -6%. The average annual Total Receivables growth rates for Jinxin Fertility Group Ltd have been 30% over the past three years , 18% over the past five years .